Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
Prolyl hydroxylase (PHD) enzymes play a critical role in the cellular responses to hypoxia through their regulation of the hypoxia inducible factor α (HIF-α) transcription factors. PHD inhibitors show promise for the treatment of diseases including anaemia, cardiovascular disease and stroke. In this...
Príomhchruthaitheoirí: | Richardson, NL, O'Malley, LJ, Weissberger, D, Tumber, A, Schofield, CJ, Griffith, R, Jones, NM, Hunter, L |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2021
|
Míreanna comhchosúla
Míreanna comhchosúla
-
The use of dioxygen by HIF prolyl hydroxylase (PHD1).
de réir: McNeill, L, et al.
Foilsithe / Cruthaithe: (2002) -
Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
de réir: Hewitson, K, et al.
Foilsithe / Cruthaithe: (2007) -
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
de réir: Appelhoff, R, et al.
Foilsithe / Cruthaithe: (2004) -
HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.
de réir: Chen, R, et al.
Foilsithe / Cruthaithe: (2014) -
HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
de réir: Chen, R, et al.
Foilsithe / Cruthaithe: (2014)